Dear Respected Users,
Hotbit is scheduled to list ARV (Ariva) on Growing Section.
Deposit function launches at: 2021.09.29 08:00 AM UTC
Trading function launches at: 2021.09.29 10:00 AM UTC
Withdrawal function launches at: 2021.09.29 10:00 AM UTC
Trading Pair: ARV/USDT
【Hotbit users exclusively enjoy “Minus Maker Means Minus Transaction Fee” mechanism. By placing and settling any maker order, the user will enjoy 0 transaction fee and an extra 0.50% of the trading volume of his/her maker order as reward on Growing Section!】
Project Name: Ariva
Abbreviation: ARV
Project Introduction:
ARIVA (ARV) is a BEP20 token that has been produced for active use in global and local tourism, as well as travel networks in the near future. It runs as a fully decentralized worldwide B2C - B2B Travel & Tourism Network.
Project is a worldwide B2C travel & tourism network where members can meet with global and local tourism service providers in the light of previous travelers' experiences and shares, make bookings with Cryptocurrency and earn crypto money from both their reservations and valuable content sharing.ARV is the tourism cryptocurrency of the near future that can be spent safely in every country of the world from its crypto money wallet, eliminating the need to carry cash or debit cards.
Token type: BEP-20
Total supply: 100,000,000,000 ARV
Official Website: https://ariva.digital/
Explorer: https://bscscan.com/token/0x6679eB24F59dFe111864AEc72B443d1Da666B360
Risk warning
The investment on cryptocurrency projects is subject to high market risks.Please make your investments cautiously. Hotbit will make best efforts to choose the cryptocurrency projects with high quality,but Hotbit will not be responsible for any of your investment losses.
Thank you for your support！
Yours truly
Hotbit Team
About us ：
Hotbit’s Official Website： https://www.hotbit.io/
Telegram ： https://t.me/Hotbit_English
Twitter： https://twitter.com/Hotbit_news
Facebook： https://www.facebook.com/hotbitexchange/
Medium： https://medium.com/@hotbit
Comments
0 comments
Article is closed for comments.